
Geffen Residence & Renewal Ltd, together with its subsidiaries, engages in the urban renewal business in Israel. Based in Ashdod.
Net income: ₪−3M, vs. ₪−3M a year earlier, i.e. −28.8%.
Revenue: ₪0M, vs. ₪0M a year earlier, i.e. +2.6%.
Operating cash flow: ₪−19M, vs. ₪−10M a year earlier, i.e. −99.6%.
Operating income: ₪−5M, vs. ₪−4M a year earlier, i.e. −37.5%.
This company's valuation multiples history is being built day by day from now on.
P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.
23 filing(s) over 12 months · on shares: 21 increase(s) and 1 decrease(s) in holdings.
| Date | Holder | Security | Direction | Quantity | Price | |
|---|---|---|---|---|---|---|
| 09/11/2026 | Hezi Bina Director | Shares | Up | 100,500 | ₪0.80 | Maya › |
| 21/10/2026 | Abou Zachi Director | Shares | Up | 720,000 | ₪0.70 | Maya › |
| 27/08/2026 | Abou Zachi Director | Shares | Up | 620,000 | ₪0.81 | Maya › |
| 06/07/2026 | Abou Zachi Director | Shares | Up | 2,515,453 | ₪0.82 | Maya › |
| 27/08/2026 | Abou Zachi Director | Shares | Up | 620,000 | ₪0.81 | Maya › |
| 27/08/2026 | NATAN GILBOA Director | Shares | Up | 617,284 | ₪0.81 | Maya › |
| 21/08/2026 | NATAN GILBOA Director | Shares | Up | 5,444 | ₪0.81 | Maya › |
| 25/06/2026 | Hezi Bina Director | Shares | Up | 30,549 | ₪0.71 | Maya › |
| 06/07/2026 | Abou Zachi Director | Shares | Up | 2,514,477 | ₪0.82 | Maya › |
| 25/06/2026 | Hezi Bina Director | Shares | Down | 30,549 | ₪0.71 | Maya › |
| 03/07/2026 | NATAN GILBOA Director | Shares | Up | 2,498 | ₪0.80 | Maya › |
| 02/07/2026 | Abou Zachi Director | Shares | Up | 69,621 | ₪0.75 | Maya › |
Filings submitted on Maya (executives, directors, shareholders above 5%). An increase or decrease in holdings may come from a purchase or sale on the exchange, but also from a grant or exercise of options (price "—": grant with no price). Bonds excluded. For details, see the filing on Maya.
Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.
Join the TA-125 group| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Total assets | 334 | 101 | 264 |
| Current assets | 82 | 20 | 20 |
| Non-current assets | 251 | 78 | 243 |
| Equity | 204 | 52 | 145 |
| of which minority interests | 23 | 9 | 23 |
| Current liabilities | 27 | 4 | 11 |
| Non-current liabilities | 103 | 45 | 108 |
| Revenue | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 |
| Operating income | −5 | −4 | −7 |
| Pre-tax income | −5 | −3 | −7 |
| Net income | −3 | −3 | −5 |
| Net income (attributable to shareholders) | −3 | −3 | −5 |
| Dividends paid | 0 | 0 | 0 |
| Operating cash flow | −19 | −10 | −17 |
In millions of shekels. The "H1" columns cover the first six months of the year.
| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Gross margin | 100.0% | 100.0% | 100.0% |
| Operating margin | −12,535.0% | −9,348.7% | −9,437.2% |
| Net margin | −8,267.5% | −6,584.6% | −6,566.7% |
| Current ratio (current assets / current liabilities) | 3,0 x | 5,3 x | 1,8 x |
| Equity / total assets | 61.0% | 51.4% | 54.9% |
The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.
Geffen Residence & Renewal Ltd, together with its subsidiaries, engages in the urban renewal business in Israel. The company was formerly known as Cannomed Medical Cannabis Industries Ltd and changed its name to Geffen Residence & Renewal Ltd in January 2023. Geffen Residence & Renewal Ltd was incorporated in 1999 and is based in Ashdod, Israel.
Source: official company profile (Yahoo Finance), summary.
No dividend paid over the past five years (source: Yahoo Finance).
Choose the companies to follow. As soon as one of them publishes its results: the key figures, their year-on-year change and the analysis in brief, by email.